BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37354769)

  • 1. Radiomics based automated quality assessment for T2W prostate MR images.
    Thijssen LCP; de Rooij M; Barentsz JO; Huisman HJ
    Eur J Radiol; 2023 Aug; 165():110928. PubMed ID: 37354769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Image Resampling on the Performance of Radiomics-Based Artificial Intelligence in Multicenter Prostate MRI.
    Bleker J; Roest C; Yakar D; Huisman H; Kwee TC
    J Magn Reson Imaging; 2024 May; 59(5):1800-1806. PubMed ID: 37572098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Learning-Based Interpretable AI for Prostate T2W MRI Quality Evaluation.
    Belue MJ; Law YM; Marko J; Turkbey E; Malayeri A; Yilmaz EC; Lin Y; Johnson L; Merriman KM; Lay NS; Wood BJ; Pinto PA; Choyke PL; Harmon SA; Turkbey B
    Acad Radiol; 2024 Apr; 31(4):1429-1437. PubMed ID: 37858505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
    Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D T2-weighted imaging to shorten multiparametric prostate MRI protocols.
    Polanec SH; Lazar M; Wengert GJ; Bickel H; Spick C; Susani M; Shariat S; Clauser P; Baltzer PAT
    Eur Radiol; 2018 Apr; 28(4):1634-1641. PubMed ID: 29134351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully automated detection of prostate transition zone tumors on T2-weighted and apparent diffusion coefficient (ADC) map MR images using U-Net ensemble.
    Wong T; Schieda N; Sathiadoss P; Haroon M; Abreu-Gomez J; Ukwatta E
    Med Phys; 2021 Nov; 48(11):6889-6900. PubMed ID: 34418108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate lesion delineation from multiparametric magnetic resonance imaging based on locality alignment discriminant analysis.
    Lin M; Chen W; Zhao M; Gibson E; Bastian-Jordan M; Cool DW; Kassam Z; Liang H; Chow TWS; Ward AD; Chiu B
    Med Phys; 2018 Oct; 45(10):4607-4618. PubMed ID: 30153334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
    Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
    J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3.0 T prostate MRI: Visual assessment of 2D and 3D T2-weighted imaging sequences using PI-QUAL score.
    Brillat-Savarin N; Wu C; Aupin L; Thoumin C; Hamzaoui D; Renard-Penna R
    Eur J Radiol; 2023 Sep; 166():110974. PubMed ID: 37453273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI.
    Khanfari H; Mehranfar S; Cheki M; Mohammadi Sadr M; Moniri S; Heydarheydari S; Rezaeijo SM
    BMC Med Imaging; 2023 Nov; 23(1):195. PubMed ID: 37993801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate.
    Johnson PM; Tong A; Donthireddy A; Melamud K; Petrocelli R; Smereka P; Qian K; Keerthivasan MB; Chandarana H; Knoll F
    J Magn Reson Imaging; 2022 Jul; 56(1):184-195. PubMed ID: 34877735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging.
    Kwak JT; Xu S; Wood BJ; Turkbey B; Choyke PL; Pinto PA; Wang S; Summers RM
    Med Phys; 2015 May; 42(5):2368-78. PubMed ID: 25979032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Multiparametric Magnetic Resonance Imaging of the Prostate at 7 T.
    Lagemaat MW; Philips BW; Vos EK; van Uden MJ; Fütterer JJ; Jenniskens SF; Scheenen TW; Maas MC
    Invest Radiol; 2017 May; 52(5):295-301. PubMed ID: 28002239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of MRI radiomics features in MR-guided radiotherapy for prostate cancer: Repeatability, reproducibility, and within-subject agreement.
    Xue C; Yuan J; Poon DM; Zhou Y; Yang B; Yu SK; Cheung YK
    Med Phys; 2021 Nov; 48(11):6976-6986. PubMed ID: 34562286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients.
    Zhang W; Mao N; Wang Y; Xie H; Duan S; Zhang X; Wang B
    Eur J Radiol; 2020 Jul; 128():109020. PubMed ID: 32371181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning for assessing image quality in bi-parametric prostate MRI: A feasibility study.
    Alis D; Kartal MS; Seker ME; Guroz B; Basar Y; Arslan A; Sirolu S; Kurtcan S; Denizoglu N; Tuzun U; Yildirim D; Oksuz I; Karaarslan E
    Eur J Radiol; 2023 Aug; 165():110924. PubMed ID: 37354768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
    Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
    Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
    Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
    Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.